µ¥Ï¸°ûRNA²âÐò£¨scRNA-seq£©ÊÇÒ»ÖÖÈÈÃŵļ¼Êõ£¬Äܹ»ÔÚµ¥Ï¸°ûˮƽÉÏÑо¿»ùÒòµÄ±í´ïģʽ£¬´Ó¶øÉîÈëÁ˽âϸ°ûÒìÖÊÐÔ¡£²»¹ý£¬ÓëµÍͨÁ¿·½·¨Ïà±È£¬¸ßͨÁ¿scRNA-seq·½·¨´Óÿ¸öϸ°ûÖлØÊÕµÄÐÅÏ¢½ÏÉÙ¡£

×î½ü£¬ÂéÊ¡Àí¹¤Ñ§ÔºµÄÑо¿ÈËԱͨ¹ý¸Ä½ø³£ÓõÄSeq-Well¼¼Êõ£¬´ó´óÌá¸ßÁË´Óϸ°ûÖÐÊÕ¼¯µÄÐÅÏ¢Á¿¡£Èç½ñ£¬ËûÃǿɴÓÿ¸öϸ°ûÖÐÊÕ¼¯Ê®±¶µÄÐÅÏ¢£¬¸ü¼ÓÉîÈëµØÁ˽âϸ°ûÖбí´ïµÄ»ùÒò£¬Õ⽫ÓÐÖúÓÚËûÃÇ·¢ÏÖ½¡¿µÏ¸°ûÓëÒ쳣ϸ°ûÖ®¼äϸ΢µ«¹Ø¼üµÄ²îÒì¡£ÕâÏî³É¹ûÓÚÖܶþ·¢±íÔÚ¡¶Immunity¡·ÔÓÖ¾ÉÏ¡£

¹²Í¬Í¨Ñ¶×÷Õß¡¢ÂéÊ¡Àí¹¤Ñ§ÔºÒ½Ñ§¹¤³ÌÓë¿ÆÑ§Ñо¿Ëù£¨IMES£©µÄºËÐijÉÔ±Alex K. Shalek±íʾ£º¡°ÏÔÈ»£¬ÕâЩ¼¼ÊõÔÚÁ˽⸴ÔÓµÄÉúÎïѧϵͳÉϾßÓе߸²ÐÔµÄDZÁ¦¡£Èç¹ûÎÒÃDz鿴һϵÁв»Í¬µÄÊý¾Ý¼¯£¬ÎÒÃǽ«ÕæÕýÁ˽⽡¿µÓë¼²²¡µÄ×´¿ö£¬ÕâÓÐÍû¸æËßÎÒÃDzÉÈ¡ºÎÖÖÖÎÁƲßÂÔ¡£¡±

¼¸Äêǰ£¬Shalek¼°ÆäͬÊ¿ª·¢³öÒ»ÖÖÃûΪSeq-WellµÄ¸ßͨÁ¿Çҵͳɱ¾µÄ²âÐò·½·¨£¬ËüÄܹ»Í¬Ê±¶Ô¶à¸öµ¥Ï¸°ûÖеÄRNA½øÐпìËÙ²âÐò¡£²»¹ý£¬ÓëijЩͨÁ¿½ÏµÍ»ò³É±¾½Ï¸ßµÄRNA²âÐò·½·¨Ïà±È£¬Ëü´Óÿ¸öϸ°ûÖлñµÃµÄÐÅÏ¢½ÏÉÙ¡£Îª´Ë£¬ËûÃÇÕâ´ÎµÄÑо¿ÖصãÊÇÖØÐ»ñµÃ¾É°æ±¾¶ªÊ§µÄһЩÐÅÏ¢¡£

ÔÚ²âÐò¹ý³ÌÖУ¬ÎªÁË»ñµÃ×ã¹»µÄDNA¿½±´ÓÃÓÚ²âÐò£¬ÈËÃÇͨ³£ÐèÒª¶ÔcDNA·Ö×Ó½øÐÐÀ©Ôö¡£È»¶ø£¬²¢·ÇËùÓеÄcDNA¶¼±»À©Ôö¡£ÎªÁËÈøü¶àµÄ·Ö×Ó¾­¹ýÀ©ÔöÕâÒ»²½£¬ËûÃǸıäÁËcDNAµÄ±ê¼Ç·½Ê½£¬¼ÓÉÏÁ˵ڶþÌõÒýÎïÐòÁУ¬ÈÃpCRø¸üÈÝÒ×À©ÔöÕâЩ·Ö×Ó¡£

Ñо¿ÈËÔ±·¢ÏÖ£¬ÔÚ²ÉÓÃÕâÖÖ¼¼Êõºó£¬ËûÃÇÄܹ»´Óÿ¸öϸ°ûÖлñµÃ¸ü¶àµÄÐÅÏ¢¡£¼ì²âµ½µÄ»ùÒòÊýÁ¿Ôö¼ÓÁËÎå±¶£¬´Óÿ¸öϸ°ûÖлØÊÕµÄRNAת¼±¾ÊýÁ¿Ôö¼ÓÁËÊ®±¶¡£ÕâЩÓйØÏ¸°ûÒò×Ó¡¢Ï¸°û±íÃæÊÜÌåºÍת¼Òò×ӵĶîÍâÐÅÏ¢ÈÃÑо¿ÈËÔ±¼ø¶¨Ï¸°ûÖ®¼äµÄϸ΢²îÒì¡£

¹²Í¬µÚÒ»×÷ÕßTravis Hughes±íʾ£º¡°Í¨¹ýÒ»¸ö·Ç³£¼òµ¥µÄ·Ö×ÓÉúÎïѧ¼¼ÇÉ£¬ÎÒÃǾÍÄܼ«´óµØÌá¸ßÿ¸öϸ°ûµÄÐÅÏ¢Á¿£¬¶øÇÒÕâ¸ö¼¼ÇɺÜÈÝÒ×ÕûºÏµ½ÏÖÓеŤ×÷Á÷³ÌÖС£¡±

Ö®ºó£¬Ñо¿ÈËÔ±ÀûÓÃÕâÖÖ¼¼ÊõÀ´·ÖÎö19ÀýƤ·ô²¡»¼ÕßµÄÔ¼40,000¸öϸ°û£¬ÕâЩ»î¼ìÑù±¾·Ö±ð´ú±íÎåÖÖ²»Í¬µÄƤ·ô²¡£ºÒøÐ¼²¡¡¢ðî´¯¡¢Âé·ç²¡¡¢°ßͺºÍ»·×´ÈâÑ¿Öס£ËûÃÇÏ£ÍûÁ˽âÕâЩ¼²²¡µÄ¹²ÐԺͲîÒì¡£

Ñо¿ÈËÔ±·¢ÏÖ£¬Ä³Ð©¼²²¡Ö®¼ä¾ßÓÐÏàËÆÐÔ¡£ÀýÈ磬Âé·ç²¡ºÍ»·×´ÈâÑ¿Ö×Öж¼³öÏÖÏàËÆµÄÑ×ÐÔTϸ°û¡£Í¬Ê±£¬ËûÃÇÒ²·¢ÏÖÁ˼²²¡¶ÀÓеÄÌØÕ÷¡£ÔÚţƤѢ»¼ÕßµÄϸ°ûÖУ¬ËûÃÇ·¢ÏÖ½ÇÖÊÐγÉϸ°ûËù±í´ïµÄ»ùÒòÄܹ»Çý¶¯Ñ×Ö¢µÄ³öÏÖ¡£

ÕâÏîÑо¿ÖвúÉúµÄÊý¾ÝÒ²½«ÎªÆäËûÑо¿ÈËÔ±Ìṩ±¦¹ó×ÊÔ´¡£¡°ÄãÓÀÔ¶²»ÖªµÀÒÔºóÒªÓÃÕâЩÊý¾Ý¼¯À´×öʲô£¬µ«²â¶¨ÁËÒ»ÇУ¬Õâ¾ÍÊÇÒ»¸ö¾Þ´óµÄ»ú»á£¬¡±Shalek˵¡£¡°½«À´£¬µ±ÎÒÃÇÑо¿±íÃæÊÜÌå¡¢ÅäÌå¡¢µ°°×ø»òÆäËû»ùÒòʱ£¬ÕâЩÐÅÏ¢½«ÍÙÊֿɵᣡ±

Ñо¿ÈËÔ±±íʾ£¬ÕâÏî¼¼Êõ»¹¿ÉÒÔÓ¦ÓÃÓÚÆäËû¼²²¡ºÍϸ°ûÀàÐÍ¡£ËûÃÇÒÑÓÃËüÀ´Ñо¿°©Ö¢ºÍ´«È¾²¡£¬°üÀ¨½áºË²¡¡¢Å±¼²¡¢HIVºÍ°£²©À­²¡¶¾£¬²¢´òËãÓÃËüÀ´·ÖÎöÓëʳÎï¹ýÃôÓйصÄÃâÒßϸ°û¡££¨ÉúÎïͨ ±¡ºÉ£©

Ô­ÎļìË÷

Second-Strand Synthesis-Based Massively parallel scRNA-Seq Reveals Cellular States and Molecular Features of Human Inflammatory Skin pathologies

DOI: https://doi.org/10.1016/j.immuni.2020.09.015